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Many new and reemerging diseases are
transmitted by arthropod vectors. Mosquitoes
transmit malaria (1,2), dengue-dengue hemor-
rhagic fever (DHF) (3-5), yellow fever (6),
Venezuelan equine encephalitis (3,7), and
filariasis (8); sand flies transmit leishmaniasis
(7); ticks transmit Lyme disease and ehrlichiosis
(9,10); fleas and lice transmit Bartonella (11);
and fleas, lice, and ticks transmit various
rickettsioses (12-14). Resistance to insecticides
has appeared in the major insect vectors from
every genus. As of 1992, the list of insecticide-
resistant vector species included 56 anopheline
and 39 culicine mosquitoes, body lice, bedbugs,
triatomids, eight species of fleas, and nine
species of ticks (15). Other insects of public
health importance, such as certain flies and
cockroaches, show resistance in all genera.
Resistance has developed to every chemical
class of insecticide, including microbial drugs
and insect growth regulators. Despite decades of
international efforts, a detailed practical descrip-
tion of insecticide resistance that would allow
control strategies to be adjusted to specific needs
remains the exception rather than the rule.
Insecticide resistance is expected to directly
and profoundly affect the reemergence of vector-
borne diseases (1), and where resistance has not
contributed to disease emergence, it is expected
to threaten disease control (15). However,
careful scrutiny of current information about
vector resistance (e.g., the World Health
Organization [WHO] resistance database and
records of control programs) shows that the full
effect of resistance on control efforts is not
known. Many instances of resistance reported
for vector species and their regional or
countrywide distribution are based on single
datasets from a single point within a country and
may be years, if not decades, old. Researching
every resistance problem and every application
of vector control is not practical. Yet control
measures have to be selected for use, often at
times of emergency. Although alternatives to
vector control with insecticides are available,
drug resistance problems (e.g., malaria) or
vaccine cost and availability (e.g., Japanese
encephalitis) make vector control an important
option (1,16). Shrinking availability of insecti-
cides as a result of resistance is exacerbated by
removal from the market of insecticides no
longer registered for public health use, especially
in the past decade; the cost to keep certain
compounds on the market is higher than can be
recouped from such use. In addition, insecticide
use is also monitored and restricted by
regulatory agencies.
The potential of resistance to interfere with
emergency use of insecticides first became
apparent in 1993 when flooding in nine
midwestern states increased the threat over the
next 2 years of arboviral disease transmission
(17). Most of the nine states affected had no
public health entomologic or vector control
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resources, and none had susceptibility data for
their vector mosquitoes. Preliminary data
showed that resistance to the insecticides
proposed for emergency use was widespread
throughout the Midwest. As a result of these
findings, a resistance surveillance laboratory
was established at the Centers for Disease
Control and Prevention (CDC), Atlanta, Georgia.
Data collected by this laboratory in the last 3
years confirm that states vary enormously in
their resources to deal with insecticide
resistance. At present, 26 states participate in
the Emerging Infectious Disease insecticide
resistance surveillance project.
We provide an update on resistance of
disease vectors to insecticides, use specific
instances of emerging resistance to illustrate
this complex, worldwide problem, and offer
strategic priorities for combating it.
Resistance Mechanisms
Insecticide resistance mechanisms (as op-
posed to insecticide avoidance behaviors impor-
tant in the control of malaria vectors) have a
biochemical basis (Figure 1). The two major
forms of biochemical resistance are target-site
resistance, which occurs when the insecticide no
longer binds to its target, and detoxification
enzyme-based resistance, which occurs when
enhanced levels or modified activities of esterases,
oxidases, or glutathione S-transferases (GST)
prevent the insecticide from reaching its site of
action. An additional mechanism based on
thermal stress response has been proposed (18),
but its importance has not been assessed.
Target-Site Mechanisms
Alterations of amino acids responsible for
insecticide binding at its site of action cause the
insecticide to be less effective or even ineffective.
The target of organophosphorus (OPs) (e.g.,
malathion, fenitrothion) and carbamate (e.g.,
propoxur, sevin) insecticides is acetylcholinest-
erase in nerve synapses, and the target of
organochlorines (DDT) and synthetic pyrethroids
are the sodium channels of the nerve sheath.
DDT-pyrethroid cross-resistance may be pro-
duced by single amino acid changes (one or both
of two known sites) in the axonal sodium channel
insecticide-binding site (19,20). This cross-
resistance appears to produce a shift in the sodium
current activation curve and cause low sensitivity
to pyrethroids (21). Similarly, cyclodiene (dieldrin)
resistance is conferred by single nucleotide
changes within the same codon of a gene for a  g-
aminobutyric acid (GABA) receptor (22). At least
five point mutations in the acetylcholinesterase
insecticide-binding site have been identified that
singly or in concert cause varying degrees of
reduced sensitivity to OPs and carbamate
insecticides (23).
Detoxification Mechanisms
The enzymes responsible for detoxification of
xenobiotics in living organisms are transcribed
Figure 1. Examples (drawn from references cited in the
text) of biochemical resistance mechanisms on the
molecular level. A. Single amino acid mutation in the
IIS6 membrane-spanning region of the sodium channel
gene that confers target-site DDT-pyrethroid resistance
in  Anopheles gambiae. The same mutated codon
produces resistance in insects as diverse as mosquitoes,
cockroaches, and flies. B. Regulatory element (found
upstream of coding sequence) termed the Barbie Box
that allows induction of insecticide detoxifying oxidase
and esterase resistance genes. Many such putative
control elements have been found associated with vector
resistance enzymes. C. Esterase A2-B2 amplicon. These
resistance esterase genes lie 5' end to 5' end within the
same amplification unit. More than 100 copies of this
amplicon may be present in a single mosquito. This is
one example of a family of amplified esterase genes.
C
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by members of large multigene families of
esterases, oxidases, and GST. Perhaps the most
common resistance mechanisms in insects are
modified levels or activities of esterase detoxifi-
cation enzymes that metabolize (hydrolyze ester
linkages) a wide range of insecticides. These
esterases comprise six families of proteins
belonging to the a/ß hydrolase fold superfamily
(24,25). In Diptera, they occur as a gene cluster
on the same chromosome (26,27). Individual
members of the gene cluster may be modified in
instances of insecticide resistance, for example,
by changing a single amino acid that converts
the specificity of an esterase to an insecticide
hydrolase (28) or by existing as multiple-gene
copies that are amplified in resistant insects
(the best studied examples are the B1 [29]
and A2-B2 [30] amplicons in Culex pipiens
and C. quinquefasciatus).
The cytochrome P450 oxidases (also termed
oxygenases) metabolize insecticides through O-,
S-, and N-alkyl hydroxylation, aliphatic hydrox-
ylation and epoxidation, aromatic hydroxylation,
ester oxidation, and nitrogen and thioether
oxidation (31). The cytochrome P450s belong to a
vast superfamily. Of the 62 families of P450s
recognized in animals and plants, at least four
(families 4,6,9,18) have been isolated from insects.
The insect P450 oxidases responsible for resistance
have belonged to family 6, which, like the
esterases, occur in Diptera as a cluster of genes
(32). Members of the cluster may be expressed as
multiple (up to five) alleles (33). Enhanced levels
of oxidases in resistant insects result from
constitutive overexpression rather than amplifi-
cation (34,35). The mechanisms of oxidase
overproduction in resistance are under extensive
investigation and appear to result from both cis-
and trans-acting factors, perhaps associated
with the phenomenon of induction (36-38).
Most organisms possess multiple GST from
two or more classes (39). GST implicated in DDT
insecticide resistance exist as clusters of genes
that have been further shuffled through the
genome by recombination (40). A number of
resistance GST genes, including multiple
forms in the same insect, have been
characterized in vectors (41-43).
Resistance to Growth Regulators,
Ivermectins, and Other Microbial Agents
Because of their more recent introduction to
vector control programs, we discuss growth
regulators, ivermectins, and other microbial
agents as a group. The initial mechanisms that
conferred resistance to insect growth regulators
were oxidase-based (44). Resistance to ivermectins
has resulted from a number of factors, including
oxidase, conjugation, and altered target-site
mechanisms (45). Vectors have not yet demon-
strated resistance to these compounds in the field.
Microbial agents such as Bacillus sphaericus
and B. thuringiensis are considered insecticides
because the principal active agents are crystal
toxins produced by the bacteria. The mecha-
nisms of resistance to B. sphaericus are not yet
defined (46,47), but more than one mechanism
seems to be involved (48). Resistance to B.
thuringiensis has resulted from reduced binding
of the toxin to the brush border in the lumen of
the insect gut (49,50) or by enhanced digestion of
toxin by gut proteases (51). The six different
toxin types in the B. thuringiensis israelensis
strain used for vector control were expected to
retard or prevent development of a comprehen-
sive resistance mechanism; however, multitoxin
resistance to B. T. israelensis has already
appeared (52,53).
Detecting and Monitoring Resistance
The initial step in identifying a potential
problem is to detect changes in the susceptibil-
ity of a population of vectorsthrough
bioassay, biochemical assay, or molecular
assay (Figure 2).
Figure 2. Cross-resistance relationships of commonly
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Bioassays
WHO has developed susceptibility bioassay
tests (available in kit form for purchase from
WHO) for mosquitoes, lice, bedbugs, reduviid
bugs, cockroaches, blackflies, houseflies, ticks,
and fleas (15). Our laboratory found that time-
mortality bioassays were more sensitive than
dose-mortality bioassays in detecting changes in
susceptibility and had better correlation with
microplate-based biochemical assays for resis-
tance mechanisms (54,55). Time-based bioassays
have been further modified through the use of
insecticide-coated glass bottles and solutions of
standard-grade insecticides or synergists; this
approach simplifies the bioassay process and
increases the amount of information that can be
obtained from a limited pool of mosquitoes (56).
Biochemical and Molecular Assays
Biochemical and molecular methods can detect
resistance mechanisms in individual insects;
therefore, they can confirm resistance with the use
of only a small number of insects. Identification of
resistance mechanisms helps determine the
cross-resistance spectrum (Figure 3), facilitates
the choice of alternative insecticides, and allows
detailed mapping of areas with resistant
populations. Specific biochemical assays have
been developed for all known resistance
mechanisms, except the modified sodium and
GABA receptor mechanisms (57-59).
Molecular information on resistance mecha-
nisms will increasingly be incorporated into
resistance diagnostic procedures. One type of
mechanism that will become much easier to
detect will be the point mutations that cause
target-site resistance or changes in detoxifica-
tion enzyme specificity. Thus far, target-site
mechanisms have been detected by polymerase
chain reaction-restriction enzyme (PCR-REN)
and PCR amplification of specific alleles (60,61).
Features of Resistance Emergence
Innumerable genetic, biologic, and opera-
tional factors influence the development of
insecticide resistance. In many respects, resis-
tance is a chaotic problem, with different
outcomes possible in a particular area, depend-
ing on the influence of diverse factors on initial
conditions. Even so, certain factors affect
resistance development throughout the world.
We discuss major resistance characteristics and
show why each manifestation of resistance is
potentially unique and therefore must be
independently evaluated.
Focal Nature of Resistance
Vector control personnel frequently assume
that resistance in a particular species occurs
throughout their control area, but in reality,
insecticide resistance is focal. In Guatemala,
sampling sites for Anopheles albimanus only a
few kilometers apart varied not only by presence
or absence of resistance, but also by level of
resistance and by dominant mechanism respon-
sible for resistance (55).
Surveillance data (Brogdon and McAllister,
unpub. data) from the United States show that
resistance to OPs in Culex mosquito species is
focal in a number of statesgenerally high in
urban areas and absent in rural sites. The higher
levels of resistance are in areas of ongoing
control activities. When resistance levels in
adjacent counties were compared, levels were
higher in areas of intensive mosquito control.
While the relative importance of agricultural
versus public health use of insecticides to
resistance development has been widely argued
Figure 3. Examples of simple diagnostic assays for
insecticide resistance include bioassays run in
treated bottles (upper) and biochemical detection and
measurement of resistance enzyme activity in
microplates (lower).609 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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(62), resistance has been associated with both
uses. Agricultural use caused resistance in
Central American An. albimanus (55). However,
in Haiti (54) and in Sudan (62), the impact of
public health spraying on development of
resistance is clear. In Sri Lanka, resistance in
one vector, An. cuilifacies, is characteristic of
public health spraying, while resistance in
another,  An. nigerrimus, has a profile that
indicates agricultural chemicals (62). Resistance
appears rapidly in areas where bed nets are used to
control mosquitoes (Western Kenya) or
sandflies (Colombia) (63; Brogdon and
McAllister, unpub. data).
Resistance and Disease-Endemic Areas
Vector control is affected not only by the focal
nature and distribution of resistance but also by
disease incidence. Resistance detection could
actually interfere with disease control programs
if adequate surveillance data are not also
collected. In Ecuador (57) we observed OPs
resistance in the malaria vector An. albimanus
in the central agricultural provinces of Guayas,
Manabi, and Los Rios, the sources of the
countrys resistance surveillance data. However,
in the northern province of Esmeraldas, where
insecticide use had been limited and an epidemic
of  Plasmodium falciparum malaria was
under way, populations were completely
susceptible. Lack of insecticide use does not
preclude immigration of resistance genes (e.g.,
the movement of esterase resistance to OPs in
C. pipiens into certain areas of France [64]).
Resistance and Disease Control
To compromise insecticide vector control, the
level of resistance must be high enough to
adversely affect disease transmission. In many
cases, vector control may not be affected by the
level of resistance. For example, an activity may
be controlling only 75% of the vector population.
If, for example, the level of resistance is lower
than 10%, resistance will not affect disease
control efforts; in this situation, increasing
surveillance and monitoring level and frequency
of resistance would be sufficient. No change in
control methods would be needed. Western
Kenya is a good operational example of the
coexistence of resistance and disease control.
Pyrethroid resistance appeared soon after bed
nets were introduced (64). After 2 years, the
resistance level had not changed significantly,
possibly because of the continual massive
introduction of susceptible genes (65). Other
reasons may explain why the presence of
insecticide resistance genes in vectors in a
control area does not mean that effective control
is not being achieved. For example, resistance
genes may not be expressed, they may be
expressed in an alternative stage of development
to that being controlled by insecticide, or the
gene detected may be a member of an alternative
gene subfamily to one that can affect the compound
being used. We have observed in An. albimanus
and  An. gambiae that resistance enzymes,
especially esterases and GST, may be expressed
only in freshly emerged adult anophelines and
may be absent in older mosquitoes, those
potentially infective for malaria (Brogdon and
McAllister, unpub. data).
Pyrethroid Resistance
Pyrethroid resistance is emerging despite
early optimism that because of its rapid
toxicologic action this newest large class of
insecticides would not produce resistance (66).
Resistance is not evolving through unique new
mechanisms; rather, existing mechanisms are
being enhanced, and cross-resistance is occur-
ring. In Guatemala, pyrethroid resistance was
first reported in an An. albimanus population
resistant to fenitrothion. When deltamethrin
was used, the esterase conferring fenitrothion
resistance was enhanced by selective pressure to
produce deltamethrin cross-resistance (67).
Additionally, we are now finding DDT-
permethrin cross-resistance due to oxidase
cross-resistance in the same mosquito. A similar
pattern of cross-resistance has been documented
for C. pipiens in Ohio. Multiresistance (two or
more resistance mechanisms in the same insect)
is becoming widespread as control programs make
sequential use of one chemical class after another.
A far more threatening development in
pyrethroid resistance is the appearance of
target-site resistance (also termed knockdown
resistance) to pyrethroids in several important
vectors in multiple locations. We have detected
the knockdown resistance mechanism in the
dengue and yellow fever vector Aedes aegypti
from Puerto Rico and Indonesia and in the
encephalitis vector C. quinquefasciatus from
Louisiana. French researchers have detected the
mechanism in An. gambiae, the primary African
vector of malaria, in several countries of West610 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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Africa (68,69). This resistance mechanism may
be a legacy of similarities in the site of action of
pyrethroids and DDT.
Prospects for Resistance Management
A National Research Council report (70) on
strategies and tactics for pesticide resistance
management described insecticide susceptibility
as a resource and resistance surveillance as an
essential step in resistance management. Resis-
tance surveillance has three objectives: 1) Provide
baseline data for program planning and pesticide
selection before the start of control operations;
2) Detect resistance at an early stage so that
timely management can be implemented (even
detection of resistance at a late stage can be
important in elucidating the causes of failure
of disease control; however, in such cases, any
management other than replacement of the pesti-
cide may not be possible); 3) Continuously monitor
the effect of control strategies on resistance.
Resistance to insecticideseven to pyre-
throidsin disease vectors is widespread. With
the availability of more sensitive and easy-to-use
surveillance techniques (56,58,59), the means for
managing resistance are at hand. A challenge to
resistance management is that efforts to control
vector-borne diseases are becoming more
diversified; the global effort to control malaria is
a case in point. In the 1950s, WHO mounted a
global effort to eradicate malaria. Failure of this
effort was caused by many factors, including
insecticide resistance. Now the best prospect for
a worldwide malaria vector control strategy
appears to be the use of pyrethroid-impregnated
bed nets, because they are less expensive than
spraying walls with residual insecticide, are
effective in reducing child deaths, and can be
better administered through a horizontal,
community-based program (71). This type of
vector control means that resistance surveil-
lance will also have to be handled and
interpreted locally. Decisions will have to be
made within local programs by the end user.
Moreover, as urbanization increases around the
world, some horizontal programs are better able
financially to contract out control and surveil-
lance activities. In the United States, local
control programs use diverse methods for vector
control to meet their specific, often unique needs
(72). Diverse methods will likely become the
characteristic approach to vector control world-
wide, given the prohibitive economics of
mounting a worldwide disease control campaign
based on vertical programs and the availability
of entrepreneurs that increasingly contract for
vector control on a city-by-city basis internation-
ally (73-75). In vertical programs, resistance
surveillance was a component more in theory
than in fact. The challenge will be to maximize
the exposure of vector control personnel and
entrepreneurs to management principles and to
make widely available the surveillance tools
required.
Priorities for the Future
Sufficient means exist to detect and manage
resistance at a higher level and with greater
effectiveness. A number of training courses and
consultations have been conducted to broaden
the base of resistance surveillance in the United
States. However, the need for resistance
surveillance information is global. Perhaps the
most cost-effective way to disseminate this
information will be the Internet.
Internationally, the increasing diversity of
vector control measures will require continued
development of simple and informative methods.
How can we use the most sensitive and
informative molecular and biochemical methods
in concert with bioassay techniques? How can
these be best simplified so that relatively
untrained personnel can use them?
While initial detection and field surveillance
for resistance will likely continue to be based
upon simple bioassay, biochemical, and molecu-
lar tools, the deeper understanding of how
resistance arises and maintains itself in
populations requires molecular genetics studies.
The most complete understanding of insecti-
cide resistance mechanisms in disease vectors
has come from studies with mosquitoes. Much
more attention is needed for resistance detection
and surveillance methods in other vector groups,
such as sand flies, triatomids, lice, fleas, and
ticks. Most important, however, is that
resistance detection be made an integral part of
all control programs. The resources for vector
control, even under emergency situations, are
limited and must be used as effectively as possible.
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